HIF-1α is essential for myeloid cell-mediated inflammation

Cell

Volumn 112, Issue 5, 2003, Pages 645-657

  Cramer, Thorsten ^a   Yamanishi, Yuji ^b   Clausen, Björn E ^d   Förster, Irmgard ^e   Pawlinski, Rafal ^f   Mackman, Nigel ^f   Haase, Volker H ^g   Jaenisch, Rudolf ^h   Corr, Maripat ^b   Nizet, Victor ^c   Firestein, Gary S ^b   Gerber, Hans Peter ⁱ   Ferrara, Napoleone ⁱ   Johnson, Randall S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

ⁱ GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; HYPOXIA INDUCIBLE FACTOR 1; REGULATOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VON HIPPEL LANDAU FACTOR; ENDOTHELIAL CELL GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LIGASE; LYMPHOKINE; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE; VASCULOTROPIN A; VON HIPPEL LINDAU PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BACTERICIDAL ACTIVITY; BONE MARROW CELL; CELL ACTIVATION; CELL AGGREGATION; CELL INFILTRATION; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; ENERGY METABOLISM; GENE EXPRESSION; GLYCOLYSIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MICROENVIRONMENT; MOUSE; NONHUMAN; OTITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN INFLAMMATION; ANIMAL; ANOXIA; CELL MOTION; FEMALE; GENETICS; IMMUNITY; IMMUNOLOGY; INFLAMMATION; MACROPHAGE; MALE; METABOLISM; MOUSE MUTANT; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PHAGOCYTOSIS;

ANIMALIA; BACTERIA (MICROORGANISMS);

ADENOSINE TRIPHOSPHATE; ANIMALS; ANOXIA; ARTHRITIS; CELL AGGREGATION; CELL MOVEMENT; CHEMOTAXIS, LEUKOCYTE; ENDOTHELIAL GROWTH FACTORS; ENERGY METABOLISM; FEMALE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNITY; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGASES; LYMPHOKINES; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; MYELOID CELLS; NEUTROPHILS; PHAGOCYTOSIS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0037423948     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(03)00154-5     Document Type: Article

References (65)

1. Arnold F., West D., Kumar S. Wound healing. the effect of macrophage and tumour derived angiogenesis factors on skin graft vascularization Br. J. Exp. Pathol. 68:1987;569-574.
2. Babior B.M. Phagocytes and oxidative stress. Am. J. Med. 109:2000;33-44.
3. Bakker A. Einige Übereinstimmungen im Stoffwechsel der Carcinomzellen und Exsudatleukocyten. Klin. Wochenschr. 6:1927;252.
4. Borregaard N., Herlin T. Energy metabolism of human neutrophils during phagocytosis. J. Clin. Invest. 70:1982;550-557.
5. Boxer L.A., Baehner R.L., Davis J. The effect of 2-deoxyglucose on guinea pig polymorphonuclear leukocyte phagocytosis. J. Cell. Physiol. 91:1977;89-102.
6. Bradley P.P., Priebat D.A., Christensen R.D., Rothstein G. Measurement of cutaneous inflammation. estimation of neutrophil content with an enzyme marker J. Invest. Dermatol. 78:1982;206-209.
7. Burke B., Tang N., Corke K.P., Tazzyman D., Ameri K., Wells M., Lewis C.E. Expression of HIF-1α by human macrophages. implications for the use of macrophages in hypoxia-regulated cancer gene therapy J. Pathol. 196:2002;204-212.
8. Buttgereit F., Burmester G.R., Brand M.D. Bioenergetics of immune functions. fundamental and therapeutic aspects Immunol. Today. 21:2000;192-199.
9. Clausen B.E., Burkhardt C., Reith W., Renkawitz R., Forster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8:1999;265-277.
10. Denko N.C., Giaccia A.J. Tumor hypoxia, the physiological link between Trousseau's syndrome (carcinoma-induced coagulopathy) and metastasis. Cancer Res. 61:2001;795-798.
11. Dvorak H.F. VPF/VEGF and the angiogenic response. Semin. Perinatol. 24:2000;75-78.
12. Elson D.A., Thurston G., Huang L.E., Ginzinger D.G., McDonald D.M., Johnson R.S., Arbeit J.M. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1α Genes Dev. 15:2001;2520-2532.
13. Fleischmann W., Kubowitz F. Über den Stoffwechsel der Leukocyten. Biochem. Z. 181:1927;395.
14. Grunstein J., Roberts W.G., Mathieu-Costello O., Hanahan D., Johnson R.S. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function. Cancer Res. 59:1999;1592-1598.
15. Haji-Michael P.G., Ladriere L., Sener A., Vincent J.L., Malaisse W.J. Leukocyte glycolysis and lactate output in animal sepsis and ex vivo human blood. Metabolism. 48:1999;779-785.
16. Hempel S.L., Monick M.M., Hunninghake G.W. Effect of hypoxia on release of IL-1 and TNF by human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 14:1996;170-176.
17. Hockel M., Vaupel P. Biological consequences of tumor hypoxia. Semin. Oncol. 28:2001;36-41.
18. Hollander A.P., Corke K.P., Freemont A.J., Lewis C.E. Expression of hypoxia-inducible factor 1α by macrophages in the rheumatoid synovium. implications for targeting of therapeutic genes to the inflamed joint Arthritis Rheum. 44:2001;1540-1544.
19. Kalbhen D.A., Koch H.J., Domenjoz R. The energy situation in the course of acute experimental inflammation. Med. Pharmacol. Exp. Int. J. Exp. Med. 16:1967;425-431.
20. Kawaguchi T., Veech R.L., Uyeda K. Regulation of energy metabolism in macrophages during hypoxia. Roles of fructose 2,6-bisphosphate and ribose 1,5-bisphosphate. J. Biol. Chem. 276:2001;28554-28561.
21. Kay N.E., Bumol T.F., Douglas S.D. Effects of 2-deoxy-D-glucose on human monocyte metabolism and function. J. Reticuloendothel. Soc. 28:1980;367-379.
22. Kellett D.N. 2-Deoxyglucose and inflammation. J. Pharm. Pharmacol. 18:1966;199-200.
23. Kempner W. The nature of leukemic blood cells as determined by their metabolism. J. Clin. Invest. 18:1939;291-300.
24. Kittlick P.D. Inflammation, glycolytic metabolism, and glycosaminoglycans. Exp. Pathol. 30:1986;1-19.
25. Kondo K., Kaelin W.G. Jr. The von Hippel-Lindau tumor suppressor gene. Exp. Cell Res. 264:2001;117-125.
26. Korganow A.S., Ji H., Mangialaio S., Duchatelle V., Pelanda R., Martin T., Degott C., Kikutani H., Rajewsky K., Pasquali J.L.et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity. 10:1999;451-461.
27. Korhonen K. Hyperbaric oxygen therapy in acute necrotizing infections. With a special reference to the effects on tissue gas tensions. Ann. Chir. Gynaecol. 89(Suppl 214):2000;7-36.
28. Kouskoff V., Korganow A.S., Duchatelle V., Degott C., Benoist C., Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell. 87:1996;811-822.
29. Krauss S., Brand M.D., Buttgereit F. Signaling takes a breath-new quantitative perspectives on bioenergetics and signal transduction. Immunity. 15:2001;497-502.
30. Levene P.A., Meyer G.M. The action of leucocytes on glucose. J. Biol. Chem. 11:1912;361-370. a.
31. Levene P.A., Meyer G.M. On the action of leucocytes on glucose, second communication. J. Biol. Chem. 12:1912;265-273. b.
32. Lewis J.S., Lee J.A., Underwood J.C., Harris A.L., Lewis C.E. Macrophage responses to hypoxia. relevance to disease mechanisms J. Leukoc. Biol. 66:1999;889-900.
33. Manjunath N., Johnson R.S., Staunton D.E., Pasqualini R., Ardman B. Targeted disruption of CD43 gene enhances T lymphocyte adhesion. J. Immunol. 151:1993;1528-1534.
34. Manns G. Determination of glycolysis metabolites in inflamed and non-inflamed paw tissue of rats. Med. Pharmacol. Exp. Int. J. Exp. Med. 17:1967;557-575.
35. Mapp P.I., Grootveld M.C., Blake D.R. Hypoxia, oxidative stress and rheumatoid arthritis. Br. Med. Bull. 51:1995;419-436.
36. Matsumoto I., Staub A., Benoist C., Mathis D. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science. 286:1999;1732-1735.
37. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., Wykoff C.C., Pugh C.W., Maher E.R., Ratcliffe P.J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 399:1999;271-275.
38. Medzhitov R., Janeway C. Jr. Innate immunity. N. Engl. J. Med. 343:2000;338-344.
39. Michl J., Ohlbaum D.J., Silverstein S.C. c2-Deoxyglucose selectively inhibits Fc and complement receptor-mediated phagocytosis in mouse peritoneal macrophages II. Dissociation of the inhibitory effects of 2-deoxyglucose on phagocytosis and ATP generation. J. Exp. Med. 144:1976;1484-1493.
40. Najafipour H., Ferrell W.R. Comparison of synovial PO2 and sympathetic vasoconstrictor responses in normal and acutely inflamed rabbit knee joints. Exp. Physiol. 80:1995;209-220.
41. Nakadate T., Yamamoto S., Aizu E., Kato R. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced increase in vascular permeability in mouse skin by lipoxygenase inhibitors. Jpn. J. Pharmacol. 38:1985;161-168.
42. Nizet V., Kim K.S., Stins M., Jonas M., Chi E.Y., Nguyen D., Rubens C.E. Invasion of brain microvascular endothelial cells by group B streptococci. Infect. Immun. 65:1997;5074-5081.
43. O'Flaherty J.T., Kreutzer D.L., Showell H.J., Ward P.A. Influence of inhibitors of cellular function on chemotactic factor-induced neutrophil aggregation. J. Immunol. 119:1977;1751-1756.
44. Ott A. Inflammation and transcutaneous measurement of oxygen pressure in dermatology. Adv. Exp. Med. Biol. 220:1987;79-82.
45. Raick A.N. Ultrastructural, histological, and biochemical alterations produced by 12-O-tetradecanoyl-phorbol-13-acetate on mouse epidermis and their relevance to skin tumor promotion. Cancer Res. 33:1973;269-286.
46. Reiss M., Roos D. Differences in oxygen metabolism of phagocytosing monocytes and neutrophils. J. Clin. Invest. 61:1978;480-488.
47. Roos D., Reiss M., Balm A.J., Palache A.M., Cambier P.H., Van Der Stijl-Neijenhuis J.S. A metabolic comparison between human blood monocytes and neutrophils. Adv. Exp. Med. Biol. 121:1979;29-36.
48. Ryan H.E., Lo J., Johnson R.S. HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J. 17:1998;3005-3015.
49. Saadi S., Wrenshall L.E., Platt J.L. Regional manifestations and control of the immune system. FASEB J. 16:2002;849-856.
50. Sawyer R.G., Spengler M.D., Adams R.B., Pruett T.L. The peritoneal environment during infection. The effect of monomicrobial and polymicrobial bacteria on pO2 and pH. Ann. Surg. 213:1991;253-260.
51. Sbarra A., Karnovsky M. The biochemical basis of phagocytosis. I. Metabolic changes during ingestion of particles by polymorphonuclear leukocytes. J. Biol. Chem. 234:1959;1355-1362.
52. Schor H., Vaday G.G., Lider O. Modulation of leukocyte behavior by an inflamed extracellular matrix. Dev. Immunol. 7:2000;227-238.
53. Seagroves T.N., Ryan H.E., Lu H., Wouters B.G., Knapp M., Thibault P., Laderoute K., Johnson R.S. Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells. Mol. Cell. Biol. 21:2001;3436-3444.
54. Semenza G.L. HIF-1 and mechanisms of hypoxia sensing. Curr. Opin. Cell Biol. 13:2001;167-171. a.
55. Semenza G.L. Hypoxia-inducible factor 1. control of oxygen homeostasis in health and disease Pediatr. Res. 49:2001;614-617. b.
56. Semenza G.L. Hypoxia-inducible factor 1. oxygen homeostasis and disease pathophysiology Trends Mol. Med. 7:2001;345-350. c.
57. Silver I.A. Measurement of pH and ionic composition of pericellular sites. Philos. Trans. R. Soc. Lond. B Biol. Sci. 271:1975;261-272.
58. Simchowitz L., Mehta J., Spilberg I. Chemotactic factor-induced generation of superoxide radicals by human neutrophils. effect of metabolic inhibitors and antiinflammatory drugs Arthritis Rheum. 22:1979;755-763.
59. Simmen H.P., Battaglia H., Giovanoli P., Blaser J. Analysis of pH, pO2 and pCO2 in drainage fluid allows for rapid detection of infectious complications during the follow-up period after abdominal surgery. Infection. 22:1994;386-389.
60. Talks K.L., Turley H., Gatter K.C., Maxwell P.H., Pugh C.W., Ratcliffe P.J., Harris A.L. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol. 157:2000;411-421.
61. Thepen T., van Vuuren A.J., Kiekens R.C., Damen C.A., Vooijs W.C., van De Winkel J.G. Resolution of cutaneous inflammation after local elimination of macrophages. Nat. Biotech. 18:2000;48-51.
62. Turner L., Scotton C., Negus R., Balkwill F. Hypoxia inhibits macrophage migration. Eur. J. Immunol. 29:1999;2280-2287.
63. VanOtteren G.M., Standiford T.J., Kunkel S.L., Danforth J.M., Strieter R.M. Alterations of ambient oxygen tension modulate the expression of tumor necrosis factor and macrophage inflammatory protein-1 α from murine alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 13:1995;399-409.
64. Weisdorf D.J., Craddock P.R., Jacob H.S. Glycogenolysis versus glucose transport in human granulocytes. differential activation in phagocytosis and chemotaxis Blood. 60:1982;888-893. a.
65. Weisdorf D.J., Craddock P.R., Jacob H.S. Granulocytes utilize different energy sources for movement and phagocytosis. Inflammation. 6:1982;245-256. b.